Wedbush reiterated their outperform rating on shares of Oculis (NASDAQ:OCS – Free Report) in a report issued on Friday morning, Benzinga reports. They currently have a $29.00 price objective on the stock. Other equities research analysts have also issued research reports about the stock. Robert W. Baird upped their price objective on shares of Oculis […]